
Based on NIH | Can head and neck cancer or its treatments cause vision problems at night, and what might be the underlying causes?
Head and neck cancers and their treatments can cause night vision problems. Mechanisms include local tumor effects near the orbit and optic nerve, late radiation toxicity, chemotherapy-related changes (e.g., cisplatin), vitamin A deficiency from malnutrition, and ocular surface dryness or glare. Evaluation with a comprehensive eye exam, treatment history review, and nutrition assessment guides management such as lubricants, updated refraction, nutrition support, and therapy modification.
Head and neck cancer and its treatments can be associated with night vision problems, and several mechanisms may contribute. [1] Vision changes can arise from the cancer’s local effects near the eye and optic pathways, from radiation-related eye toxicity, from chemotherapy side effects, and from nutritional deficiencies such as vitamin A deficiency that impair dark adaptation. [1] [2] [3]
How cancer itself can affect vision
- Local tumor spread or pressure effects: Cancers in the sinonasal region, orbit-adjacent skull base, or salivary areas can involve the orbital muscles or optic nerve, leading to visual symptoms that may include difficulty in low light. [1] The orbit can be threatened by adjacent head and neck tumors due to close anatomic relationships with sinuses, nasal cavity, and skull base, potentially impacting sight if structures are invaded or compressed. [4]
Radiation therapy–related causes
- Late ocular effects after head and neck radiation: Radiation to areas near the eyes can lead to long‑term changes such as cloudy or blurred vision, glare/halos, sensitivity to light, and trouble seeing in the dark. [2] These effects may appear months to years later and can vary with dose and proximity of the treatment fields to ocular structures. [5]
Chemotherapy and immunotherapy effects
- Platinum agents (cisplatin): Blurred vision and altered color perception have been reported, especially with higher cumulative doses; while these changes are often reversible after stopping the drug, they can interfere with low‑light vision and contrast sensitivity. [3] The color changes can include loss of blue–yellow discrimination and irregular macular pigmentation on eye exam. [6] [7]
- Combination regimens for recurrent/metastatic disease: Treatments that include carboplatin, fluorouracil, and checkpoint inhibitors can be associated with eye pain, redness, blurred vision, and other visual changes, which may worsen night driving or dark adaptation. [8] [9]
Nutrition and vitamin A deficiency
- Vitamin A deficiency and night blindness: Poor night vision (night blindness) is a classic early sign of vitamin A deficiency because vitamin A is essential for the retinal photopigments that enable dark adaptation. [10] Cancer in the head and neck is often accompanied by nutrition challenges due to pain, swallowing difficulty, altered taste, and treatment side effects, which can lead to micronutrient deficits. [11]
- Evidence linking head and neck tumors with impaired dark adaptation: Studies have found delayed dark adaptation in people with head and neck tumors, with significantly reduced serum vitamin A levels compared to controls, suggesting long-standing deficiency likely due to malnutrition. [12] [13]
Other contributors
- Dry eye and surface irritation: Therapies can cause dry, gritty, or watery eyes; an unstable tear film can reduce contrast sensitivity and worsen night glare. [2]
- Photosensitivity and glare: Sensitivity to light and halos around bright lights have been noted after radiation, which can make nighttime vision particularly challenging. [2]
What to watch for
- New or worsening difficulty seeing in low light, glare driving at night, halos around lights, blurred vision, reduced color discrimination, eye pain or redness, and any rapid change in vision should prompt evaluation. [2] [6]
Practical evaluation pathway
- Eye exam: A comprehensive ophthalmic evaluation including visual acuity, refraction, slit-lamp exam, dilated fundus exam, color vision testing, and tests of dark adaptation when available can help pinpoint the cause. [6]
- Treatment history review: Field maps/doses from radiation and cumulative chemotherapy doses help correlate symptoms with exposure. [5]
- Nutrition assessment and labs: Consider checking vitamin A status and overall nutrition when there is weight loss, poor intake, or swallowing problems. [12] [13]
Management approaches
- Address dry eye: Lubricating drops or gels, eyelid hygiene, and environmental modifications may improve quality of vision at night. [2]
- Correct refractive issues and glare: Updated glasses, anti‑reflective coatings, and avoiding night driving until stable may help. [2]
- Nutritional support: If deficiency is suspected, coordinated care with oncology nutrition to improve intake and, when appropriate, careful vitamin A repletion may be considered, guided by clinicians due to toxicity risks from excess supplementation. [10]
- Modify cancer therapy when indicated: If a drug is implicated, clinicians may consider dose adjustments or discontinuation; some visual changes with cisplatin have improved after stopping treatment. [3]
- Specialist referral: Neuro-ophthalmology or rehabilitation services can help adapt to persistent changes and maintain independence in daily activities. [1] [14]
Quick reference: Potential causes of night vision problems in head and neck cancer
| Category | How it affects night vision | Typical clues | What can help |
|---|---|---|---|
| Local tumor effects | Involvement of orbital muscles/optic nerve; reduced visual function in dim light | Double vision, field defects, pain, proptosis | Urgent ophthalmic/neuro-ophthalmic evaluation; imaging; oncologic management [1] [4] |
| Radiation late effects | Trouble seeing in the dark, glare/halos, blurred vision from ocular surface, lens, retinal or nerve changes | History of head/neck radiation; symptoms months–years later | Eye surface care, glare control, refraction, ophthalmology follow‑up [2] [5] |
| Chemotherapy toxicity (e.g., cisplatin) | Blurred vision, altered color perception impairing contrast in low light | During or after cycles; dose-related | Review regimen; consider modification; ophthalmology assessment; often improves after stopping agent [3] [6] |
| Vitamin A deficiency | Night blindness from impaired dark adaptation | Weight loss, poor intake, swallowing issues | Nutrition assessment and supervised repletion; address dysphagia and intake barriers [12] [13] [10] |
| Ocular surface dryness | Tear film instability reduces contrast and increases glare | Dry, gritty, watery, light sensitivity | Lubricants, eye care measures, environment adjustments [2] |
Key takeaways
- Night vision problems can occur due to the cancer’s location, radiation exposure, certain chemotherapies, and vitamin A deficiency from malnutrition. [1] [2] [3] [12]
- Many causes are manageable or reversible if identified early, so reporting symptoms and getting targeted evaluation can be very helpful. [3] [2]
Related Questions
Sources
- 1.^abcdefSupport for Head & Neck Cancer(nyulangone.org)
- 2.^abcdefghijkPatient information - Skin cancer - External Beam Radiation Therapy (EBRT) - melanoma post -operative(eviq.org.au)
- 3.^abcdefCisplatin Injection Rx only(dailymed.nlm.nih.gov)
- 4.^abThe risk to the orbit in head and neck cancer.(pubmed.ncbi.nlm.nih.gov)
- 5.^abcRadiation therapy - Mayo Clinic(mayoclinic.org)
- 6.^abcdDailyMed - CISPLATIN injection(dailymed.nlm.nih.gov)
- 7.^↑DailyMed - CISPLATIN injection(dailymed.nlm.nih.gov)
- 8.^↑Patient information - Head and neck cancer recurrent or metastatic - Carboplatin, fluorouracil and pembrolizumab(eviq.org.au)
- 9.^↑Patient information - Head and neck cancer recurrent or metastatic - Carboplatin, fluorouracil and pembrolizumab(eviq.org.au)
- 10.^abcVitamina A: MedlinePlus enciclopedia médica(medlineplus.gov)
- 11.^↑Radiation Therapy for Head & Neck Cancer(nyulangone.org)
- 12.^abcd[Vitamin A level and dark adaptation in patients with tumors].(pubmed.ncbi.nlm.nih.gov)
- 13.^abc[Dark adaptation of patients with head and neck tumors].(pubmed.ncbi.nlm.nih.gov)
- 14.^↑Support for Head & Neck Cancer(nyulangone.org)
Important Notice: This information is provided for educational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before making any medical decisions.


